Sorry, you need to enable JavaScript to visit this website.

A study of two new encorafenib formulations and the effect of a proton-pump inhibitor on these formulations in adult healthy participants

A study of two new encorafenib formulations and the effect of a proton-pump inhibitor on these formulations in adult healthy participants. A Phase 1, Randomized, Open-Label Study in Healthy Participants to Estimate the Bioavailability of Two New Encorafenib Formulations Relative to the Current Formulation and to Evaluate the Effect of a Proton-Pump Inhibitor on Encorafenib Plasma Pharmacokinetics.

Category & Conditions: Cancer
Medicine: BRAFTOVI® CAPSULES(ENCORAFENIB)
ClinicalTrials.gov Identifier (NCT): NCT05446142
Protocol ID: C4221024
PrintDownload
Open Plain Language Summary Result: Click here